| Accession |
PRJCA017244 |
| Title |
HLX10 versus placebo in combination with chemotherapy in patients with locally Advanced/Metastatic Oesophageal Squamous Cell Carcinoma |
| Relevance |
Medical |
| Data types |
Biomarker Data
|
| Organisms |
Homo sapiens
|
| Description |
Primary objective: to compare the clinical efficacy of HLX10 versus placebo in combination with chemotherapy as first-line therapy in patients with locally adcanced/metastatic ESCC. Second objective: to compare the safety and tolerability of HLX10 versus placebo in combination with chemotherapy as first-line therapy in patients with locally advanced/metastatic ESCC. |
| Sample scope |
Multiisolate |
| Release date |
2023-05-27 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Yan
Song (song-yan@hotmail.com)
|
| Organization |
National Cancer Center/ cancer hospital, Chinese Academy of Medical Sciences & and Peking Union Medical College |
| Submission date |
2023-05-24 |
